CX3CL1 and Parkinson disease: Previous reports indicated that CX3CL1 exerts a neuroprotective effect by targeting activated microglia [69, 70], which has been demonstrated in rodent models of stroke, Parkinson’s disease, and Alzheimer’s disease [35–37].